|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:SAP30-GALNT7 (FusionGDB2 ID:78653) |
Fusion Gene Summary for SAP30-GALNT7 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SAP30-GALNT7 | Fusion gene ID: 78653 | Hgene | Tgene | Gene symbol | SAP30 | GALNT7 | Gene ID | 8819 | 117248 |
| Gene name | Sin3A associated protein 30 | polypeptide N-acetylgalactosaminyltransferase 15 | |
| Synonyms | - | GALNACT15|GALNT13|GALNT7|GALNTL2|PIH5|pp-GalNAc-T15 | |
| Cytomap | 4q34.1 | 3p25.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | histone deacetylase complex subunit SAP3030 kDa Sin3-associated polypeptideSin3 corepressor complex subunit SAP30Sin3-associated polypeptide, 30kDaSin3A-associated protein, 30kDasin3-associated polypeptide p30sin3-associated polypeptide, 30 kDa | polypeptide N-acetylgalactosaminyltransferase 15UDP-GalNAc transferase T15UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15UDP-N-acetyl-alpha-D-ga | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | Q86SF2 | |
| Ensembl transtripts involved in fusion gene | ENST00000504618, ENST00000296504, | ENST00000265000, ENST00000512285, ENST00000502407, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 3 X 2 X 3=18 |
| # samples | 1 | 3 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: SAP30 [Title/Abstract] AND GALNT7 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | SAP30(174295188)-GALNT7(174169131), # samples:1 GALNT7(174090112)-SAP30(174294541), # samples:4 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SAP30 | GO:0006355 | regulation of transcription, DNA-templated | 9651585 |
| Fusion gene breakpoints across SAP30 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across GALNT7 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BLCA | TCGA-C4-A0F0-01A | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
Top |
Fusion Gene ORF analysis for SAP30-GALNT7 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000504618 | ENST00000265000 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
| intron-3CDS | ENST00000504618 | ENST00000512285 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
| intron-intron | ENST00000504618 | ENST00000502407 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
| In-frame | ENST00000296504 | ENST00000265000 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
| In-frame | ENST00000296504 | ENST00000512285 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
| 5CDS-intron | ENST00000296504 | ENST00000502407 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000296504 | SAP30 | chr4 | 174295188 | + | ENST00000265000 | GALNT7 | chr4 | 174169131 | + | 4878 | 780 | 120 | 2627 | 835 |
| ENST00000296504 | SAP30 | chr4 | 174295188 | + | ENST00000512285 | GALNT7 | chr4 | 174169131 | + | 2196 | 780 | 120 | 1805 | 561 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000296504 | ENST00000265000 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + | 0.000366518 | 0.99963343 |
| ENST00000296504 | ENST00000512285 | SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169131 | + | 0.00104822 | 0.9989518 |
Top |
Fusion Genomic Features for SAP30-GALNT7 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169130 | + | 5.65E-06 | 0.9999944 |
| SAP30 | chr4 | 174295188 | + | GALNT7 | chr4 | 174169130 | + | 5.65E-06 | 0.9999944 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SAP30-GALNT7 |
| Go to FGviewer for the breakpoints of chr4:174295188-chr4:174169131 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | GALNT7 |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Glycopeptide transferase involved in O-linked oligosaccharide biosynthesis, which catalyzes the transfer of an N-acetyl-D-galactosamine residue to an already glycosylated peptide. In contrast to other proteins of the family, it does not act as a peptide transferase that transfers GalNAc onto serine or threonine residue on the protein receptor, but instead requires the prior addition of a GalNAc on a peptide before adding additional GalNAc moieties. Some peptide transferase activity is however not excluded, considering that its appropriate peptide substrate may remain unidentified. {ECO:0000269|PubMed:10544240, ECO:0000269|PubMed:11925450}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | SAP30 | chr4:174295188 | chr4:174169131 | ENST00000296504 | + | 3 | 4 | 15_59 | 180.0 | 221.0 | Compositional bias | Ala-rich |
| Hgene | SAP30 | chr4:174295188 | chr4:174169131 | ENST00000296504 | + | 3 | 4 | 67_115 | 180.0 | 221.0 | Zinc finger | Note=Atypical |
| Tgene | GALNT7 | chr4:174295188 | chr4:174169131 | ENST00000265000 | 0 | 12 | 532_652 | 42.0 | 658.0 | Domain | Ricin B-type lectin | |
| Tgene | GALNT7 | chr4:174295188 | chr4:174169131 | ENST00000265000 | 0 | 12 | 206_317 | 42.0 | 658.0 | Region | Note=Catalytic subdomain A | |
| Tgene | GALNT7 | chr4:174295188 | chr4:174169131 | ENST00000265000 | 0 | 12 | 381_443 | 42.0 | 658.0 | Region | Note=Catalytic subdomain B |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | GALNT7 | chr4:174295188 | chr4:174169131 | ENST00000265000 | 0 | 12 | 1_6 | 42.0 | 658.0 | Topological domain | Cytoplasmic | |
| Tgene | GALNT7 | chr4:174295188 | chr4:174169131 | ENST00000265000 | 0 | 12 | 30_657 | 42.0 | 658.0 | Topological domain | Lumenal | |
| Tgene | GALNT7 | chr4:174295188 | chr4:174169131 | ENST00000265000 | 0 | 12 | 7_29 | 42.0 | 658.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Top |
Fusion Gene Sequence for SAP30-GALNT7 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000296504_ENST00000265000_TCGA-C4-A0F0-01A_SAP30_chr4_174295188_+_GALNT7_chr4_174169131_length(transcript)=4878nt_BP=780nt CCCCATGTGACAGTGAGCGGGGTCCCCGCTCCAGGAGACGCTCGAGTCTGCGTCCCGGCCCTCAGCACTGTCCACTGTTTCGGTGCCAGC AGAGACCAGCAGGCCCGGGACAGTTGGTGTTTGGCCGTGCCGCTGTCTAACTTGGTGTGCAGAGTGAATTGCCGCTGCCGGAGCGGAGAG AGGCGGAGCGGCCAGGAGAGAGGGGATTTCTGTCAGCGCCGGCCTCGGGAGCTCGGAGACATGAACGGCTTCACGCCTGACGAGATGAGC CGCGGCGGGGATGCGGCCGCCGCAGTGGCCGCAGTGGTCGCTGCCGCGGCCGCCGCCGCCTCGGCGGGGAACGGGACCGGCGCGGGCACC GGGGCTGAGGTGCCGGGCGCGGGGGCGGTCTCAGCGGCTGGGCCCCCGGGGGCGGCCGGGCCGGGCCCCGGGCAACTGTGCTGCCTGCGG GAGGATGGTGAGCGGTGCGGCCGGGCGGCAGGCAACGCCAGCTTCAGCAAGAGGATCCAGAAGAGCATCTCCCAGAAGAAGGTGAAGATC GAGCTGGATAAGAGCGCAAGGCATCTTTACATATGTGATTATCATAAAAACTTAATTCAGAGTGTTCGAAACAGAAGAAAGAGAAAAGGG AGTGATGATGATGGAGGTGATTCACCTGTTCAAGATATTGATACCCCAGAGGTTGATTTATACCAATTACAAGTAAATACACTTAGGAGA TACAAAAGACACTTCAAGCTACCAACCAGACCAGGACTTAATAAAGCACAACTTGTTGAGGAAGACAGAGATGTCAATGACCCCATGCCC AACCGAGGCGGCAATGGACTAGCTCCTGGGGAGGACAGATTCAAACCTGTGGTACCATGGCCTCATGTTGAAGGAGTAGAAGTGGACTTA GAGTCTATTAGAAGAATAAACAAGGCCAAAAATGAACAAGAGCACCATGCTGGAGGAGATTCCCAGAAAGATATCATGCAGAGGCAGTAT CTCACATTTAAGCCTCAGACATTCACCTACCATGATCCTGTGCTTCGCCCAGGGATCCTCGGTAACTTTGAACCCAAAGAACCTGAGCCT CCTGGAGTGGTTGGTGGCCCTGGAGAGAAAGCCAAGCCATTGGTTTTGGGACCAGAATTCAAACAAGCAATTCAAGCCAGCATTAAAGAG TTTGGATTTAACATGGTGGCAAGTGACATGATCTCACTGGACCGCAGCGTCAATGACTTACGCCAAGAAGAATGCAAGTATTGGCATTAT GATGAAAACTTGCTCACTTCGAGCGTTGTCATTGTCTTCCATAATGAAGGATGGTCAACCCTCATGAGAACAGTCCACAGTGTAATTAAA AGGACTCCAAGGAAATATTTAGCAGAAATTGTGTTAATTGACGATTTCAGTAATAAAGAACACTTAAAAGAAAAACTGGATGAATATATT AAGCTGTGGAATGGCCTAGTGAAGGTATTTCGAAATGAAAGAAGGGAAGGTTTAATTCAAGCACGAAGTATTGGTGCTCAGAAGGCTAAA CTTGGACAGGTTTTGATATACCTTGATGCCCACTGTGAGGTGGCAGTTAACTGGTATGCACCACTTGTAGCTCCCATATCTAAGGACAGA ACCATTTGCACTGTGCCGCTTATAGATGTCATAAATGGCAACACATATGAAATTATACCCCAAGGGGGTGGTGATGAAGATGGGTATGCC CGAGGAGCATGGGATTGGAGTATGCTCTGGAAACGGGTGCCTCTGACCCCTCAAGAGAAGAGACTGAGAAAGACAAAAACTGAACCGTAT CGGTCCCCAGCCATGGCTGGGGGATTATTTGCCATTGAACGAGAGTTCTTCTTTGAATTGGGTCTCTATGATCCAGGTCTCCAGATTTGG GGTGGTGAAAACTTTGAGATCTCATACAAGATATGGCAGTGTGGTGGCAAATTATTATTTGTTCCTTGTTCTCGTGTTGGACATATCTAC CGTCTTGAGGGCTGGCAAGGAAATCCTCCGCCCATTTATGTTGGGTCTTCTCCAACTCTGAAGAATTATGTTAGAGTTGTGGAGGTTTGG TGGGATGAATATAAAGACTACTTCTATGCTAGTCGTCCTGAATCGCAGGCATTACCATATGGGGATATATCGGAGCTGAAAAAATTTCGA GAAGATCACAACTGCAAAAGTTTTAAGTGGTTCATGGAAGAAATAGCTTATGATATCACCTCACACTACCCTTTGCCACCCAAAAATGTT GACTGGGGAGAAATCAGAGGCTTCGAAACTGCTTACTGCATTGATAGCATGGGAAAAACAAATGGAGGCTTTGTTGAACTAGGACCCTGC CACAGGATGGGAGGGAATCAGCTTTTCAGAATCAATGAAGCAAATCAACTCATGCAGTATGACCAGTGTTTGACAAAGGGAGCTGATGGA TCAAAAGTTATGATTACACACTGTAATCTAAATGAATTTAAGGAATGGCAGTACTTCAAGAACCTGCACAGATTTACTCATATTCCTTCA GGAAAGTGTTTAGATCGCTCAGAGGTCCTGCATCAAGTATTCATCTCCAATTGTGACTCCAGTAAAACGACTCAAAAATGGGAAATGAAT AACATCCATAGTGTTTAGAGAGAAAAAAATAAACCAATAACCTACCTACTGACAAGTAAATTTATACAGGACTGAAAACCGCCTGAAACC TGCTGCAACTATTGTTATTAACTCTGTATAGCTCCAAACCTGGAACCTCCTGATCAGTTTGAAGGACATTGATAAACTGTGATTTTACAA TAACATTATCATCTGCAGTTACTGTTTACAAGACTGCTTTTACCTTAAACTTTGTAGATGTTTACATCTTTTTGTTGTGTTTTAAGATGA TGTTGGTAATTTGTGCCTTTAGCTCTGTTTTATTAGACAGAGTTAAAGCATGTTGTCTTCTTTGGGATTACACTCAGGGGTCTGAAAGGC AGTTTGATTTTTATTTTTAACACACTTGAAAAAAGGTTGGAGTAGCCAGACTTTCATATATAACTTGGTGATTATCAACCTGTTGTGTCT TTATTTAATTTTACATCTTTTTGAAGCACTGCCACAGGTTATTAGCCAAGGTGGCCTTCCTTCACAGTCATGCTGCTTTTTTGAAAGGTG AATTTCAACACATTTAGTGCCTCTTTCATTTCTCAGTATATATTTCAAGAGCTTGTGATGAAATCTATAGGATGGTAATGATGGACTTGT CACCTGTATGGGGAATACTTTTACTACTCAGAAATGAATTTATGTGCTGCCATTTGCTATAAAGTTGAACTTTGTATGGCTTGAAAAAGA AATGACAATATGGAACATCCCAAGGCTGTCCCATAGGGTTGGAAGTTGTGTAGCATTCACTCCCTTACCTACTGGCATTCCCAGTGCCCT CTGTCCATACCTACTTCTAGGATTGCAAAGGAGTCTTCCAACTAGAGAAAAATTGTCCACTGACATTTGGGATTTACTTTTCTCCAATAC CTGCCAATACAGAAAACTATTATCAGTTGTTATTGTTATCCCTTGAAAGCGAGGGTGACAAAAACAACAAAACACCGTTATAAACACATC AAAGGTTCATTCTGACTGAGGTAAGACTTTCCAAGCCCTTGTTAGATTAGGCCTTATAAAACTTGTGTGCATTATAACCTAAGCTGTGCA ACCTGTGAAGCCAAGAGTGAACTGATGTTTCATTTATATTTTCATCCAAATGACATTATCTGCACGTTTTTAAAATTTAAAAACAAAGGA CTATTTAAAAATACAGTTTATTAACAAACGTGAACTACTTTCTGTTACATTAGGTGTTCCCTAGTGTTTCTTAATTTCTTTTTAGAAAGT GTATTTTTATTAGTATTTTTCCGGTGAACAGAAGATTTGTTTGGATTTAAACATTTACTAAGACAGTACCTATTAGGAAAACCAAATATT GCAAATGGTCAATTCGATTTTAATTTCTCAAAAGATACTCTGTTATCCAGAAGATTAAAATGCCTACATTGAGTGCTTAAAAAAAAAAAA ACAACTGTGATGATGTGAGCAGAATGGCAAGTAAGTTAAGCATTTTTGATCCTGTAATCATGGTATCATTACAATGAAAGGAATTCACAA ACTACTGCCAGAGGAAGTTTGTTTTTTAATTTAAGAGGGAAATATAACCTATAAATTTGTTTCTTCCAAGCTTAGCTCTTAAATTTGGAG ACTCAAAGTTAAACATCCTCAACAGAGTTTTATTTATAATTTTGAATTGTCAATTTGTATTTTGCTACTGATCTGTGATCAACCATTTTA ACTTTCATCTCTAGGGATGTTTAACATTTATAATTGCAAAATAAACCAACTATAAAAAAAGAAACTAAGAGAGAATTGGTACTTTAATTA CTTGTGTGTTTGCAAATAGGCTCCATTTTCCATGTTGAGTAGATTATAACCTTATTAACTATGCATAGGCCTAAGAAAGGTGGCAATGAA CTGTGCATGTAAATTTTAAATGGGTACTTTGTGCAATTCGTTAAAAGAAGATACTCTATGAATATGATTCTATATATTGAAATCAGAAAA CCTACCAAACAAAAACATCAGAAGCTGCTGCCATAATGACTATTTTCTACTGTAGGCTGCTTTGGAAATAATTCCCATATCCTTGCTTTG TAAGTTGGTAATATCACTATGCATTTCTACACATTTTATAAATTTGATTTATGCAGATTTTGATACACTGTATGTTTCTGTAGAAATTGT ATAAATATTCAAAATTTTATTAGGATAAATTTGAGAAACTTACGTATATCTTAATTCTGGGTTGCTTGTTTTTTAGGTGACAAAAATAAA >In-frame_ENST00000296504_ENST00000265000_TCGA-C4-A0F0-01A_SAP30_chr4_174295188_+_GALNT7_chr4_174169131_length(amino acids)=835AA_start in transcript=120_stop in transcript=2627 MAVPLSNLVCRVNCRCRSGERRSGQERGDFCQRRPRELGDMNGFTPDEMSRGGDAAAAVAAVVAAAAAAASAGNGTGAGTGAEVPGAGAV SAAGPPGAAGPGPGQLCCLREDGERCGRAAGNASFSKRIQKSISQKKVKIELDKSARHLYICDYHKNLIQSVRNRRKRKGSDDDGGDSPV QDIDTPEVDLYQLQVNTLRRYKRHFKLPTRPGLNKAQLVEEDRDVNDPMPNRGGNGLAPGEDRFKPVVPWPHVEGVEVDLESIRRINKAK NEQEHHAGGDSQKDIMQRQYLTFKPQTFTYHDPVLRPGILGNFEPKEPEPPGVVGGPGEKAKPLVLGPEFKQAIQASIKEFGFNMVASDM ISLDRSVNDLRQEECKYWHYDENLLTSSVVIVFHNEGWSTLMRTVHSVIKRTPRKYLAEIVLIDDFSNKEHLKEKLDEYIKLWNGLVKVF RNERREGLIQARSIGAQKAKLGQVLIYLDAHCEVAVNWYAPLVAPISKDRTICTVPLIDVINGNTYEIIPQGGGDEDGYARGAWDWSMLW KRVPLTPQEKRLRKTKTEPYRSPAMAGGLFAIEREFFFELGLYDPGLQIWGGENFEISYKIWQCGGKLLFVPCSRVGHIYRLEGWQGNPP PIYVGSSPTLKNYVRVVEVWWDEYKDYFYASRPESQALPYGDISELKKFREDHNCKSFKWFMEEIAYDITSHYPLPPKNVDWGEIRGFET AYCIDSMGKTNGGFVELGPCHRMGGNQLFRINEANQLMQYDQCLTKGADGSKVMITHCNLNEFKEWQYFKNLHRFTHIPSGKCLDRSEVL -------------------------------------------------------------- >In-frame_ENST00000296504_ENST00000512285_TCGA-C4-A0F0-01A_SAP30_chr4_174295188_+_GALNT7_chr4_174169131_length(transcript)=2196nt_BP=780nt CCCCATGTGACAGTGAGCGGGGTCCCCGCTCCAGGAGACGCTCGAGTCTGCGTCCCGGCCCTCAGCACTGTCCACTGTTTCGGTGCCAGC AGAGACCAGCAGGCCCGGGACAGTTGGTGTTTGGCCGTGCCGCTGTCTAACTTGGTGTGCAGAGTGAATTGCCGCTGCCGGAGCGGAGAG AGGCGGAGCGGCCAGGAGAGAGGGGATTTCTGTCAGCGCCGGCCTCGGGAGCTCGGAGACATGAACGGCTTCACGCCTGACGAGATGAGC CGCGGCGGGGATGCGGCCGCCGCAGTGGCCGCAGTGGTCGCTGCCGCGGCCGCCGCCGCCTCGGCGGGGAACGGGACCGGCGCGGGCACC GGGGCTGAGGTGCCGGGCGCGGGGGCGGTCTCAGCGGCTGGGCCCCCGGGGGCGGCCGGGCCGGGCCCCGGGCAACTGTGCTGCCTGCGG GAGGATGGTGAGCGGTGCGGCCGGGCGGCAGGCAACGCCAGCTTCAGCAAGAGGATCCAGAAGAGCATCTCCCAGAAGAAGGTGAAGATC GAGCTGGATAAGAGCGCAAGGCATCTTTACATATGTGATTATCATAAAAACTTAATTCAGAGTGTTCGAAACAGAAGAAAGAGAAAAGGG AGTGATGATGATGGAGGTGATTCACCTGTTCAAGATATTGATACCCCAGAGGTTGATTTATACCAATTACAAGTAAATACACTTAGGAGA TACAAAAGACACTTCAAGCTACCAACCAGACCAGGACTTAATAAAGCACAACTTGTTGAGGAAGACAGAGATGTCAATGACCCCATGCCC AACCGAGGCGGCAATGGACTAGCTCCTGGGGAGGACAGATTCAAACCTGTGGTACCATGGCCTCATGTTGAAGGAGTAGAAGTGGACTTA GAGTCTATTAGAAGAATAAACAAGGCCAAAAATGAACAAGAGCACCATGCTGGAGGAGATTCCCAGAAAGATATCATGCAGAGGCAGTAT CTCACATTTAAGCCTCAGACATTCACCTACCATGATCCTGTGCTTCGCCCAGGGATCCTCGGTAACTTTGAACCCAAAGAACCTGAGCCT CCTGGAGTGGTTGGTGGCCCTGGAGAGAAAGCCAAGCCATTGGTTTTGGGACCAGAATTCAAACAAGCAATTCAAGCCAGCATTAAAGAG TTTGGATTTAACATGGTGGCAAGTGACATGATCTCACTGGACCGCAGCGTCAATGACTTACGCCAAGAAGAATGCAAGTATTGGCATTAT GATGAAAACTTGCTCACTTCGAGCGTTGTCATTGTCTTCCATAATGAAGGATGGTCAACCCTCATGAGAACAGTCCACAGTGTAATTAAA AGGACTCCAAGGAAATATTTAGCAGAAATTGTGTTAATTGACGATTTCAGTAATAAAGAACACTTAAAAGAAAAACTGGATGAATATATT AAGCTGTGGAATGGCCTAGTGAAGGTATTTCGAAATGAAAGAAGGGAAGGTTTAATTCAAGCACGAAGTATTGGTGCTCAGAAGGCTAAA CTTGGACAGGTTTTGATATACCTTGATGCCCACTGTGAGGTGGCAGTTAACTGGTATGCACCACTTGTAGCTCCCATATCTAAGGACAGA ACTACATGTACTGTGCCTCTAATAGATTACATAGATGGGAATGATTATTCCATTGAACCACAGCAAGGTGGGGATGAAGATGGTTTTGCC AGAGGGGCCTGGGACTGGAGTTTACTATGGAAACGTATTCCTCTAAGCCACAAGGAAAAGGCCAAAAGAAAACATAAAACTGAACCTTAT CGGTAAAGACTATTACTTTATTTTCTTATGTTGAATGTTTATCTAAGTTCTTTTTTTTTTCTTCCCCATGAACTCGTATAAATGTGTGGG TCCATACATACGCTTCCATTTGATCTTTGCTGCCATCAACACAATACAGAACCATTTGCACTGTGCCGCTTATAGATGTCATAAATGGCA ACACATATGAAATTATACCCCAAGGGGGTGGTGATGAAGATGGGTATGCCCGAGGAGCATGGGATTGGAGTATGCTCTGGAAACGGGTGC CTCTGACCCCTCAAGAGAAGAGACTGAGAAAGACAAAAACTGAACCGTATCGGTAATCACTAAATCACTTACATATTTTTCTTTTCTCCA >In-frame_ENST00000296504_ENST00000512285_TCGA-C4-A0F0-01A_SAP30_chr4_174295188_+_GALNT7_chr4_174169131_length(amino acids)=561AA_start in transcript=120_stop in transcript=1805 MAVPLSNLVCRVNCRCRSGERRSGQERGDFCQRRPRELGDMNGFTPDEMSRGGDAAAAVAAVVAAAAAAASAGNGTGAGTGAEVPGAGAV SAAGPPGAAGPGPGQLCCLREDGERCGRAAGNASFSKRIQKSISQKKVKIELDKSARHLYICDYHKNLIQSVRNRRKRKGSDDDGGDSPV QDIDTPEVDLYQLQVNTLRRYKRHFKLPTRPGLNKAQLVEEDRDVNDPMPNRGGNGLAPGEDRFKPVVPWPHVEGVEVDLESIRRINKAK NEQEHHAGGDSQKDIMQRQYLTFKPQTFTYHDPVLRPGILGNFEPKEPEPPGVVGGPGEKAKPLVLGPEFKQAIQASIKEFGFNMVASDM ISLDRSVNDLRQEECKYWHYDENLLTSSVVIVFHNEGWSTLMRTVHSVIKRTPRKYLAEIVLIDDFSNKEHLKEKLDEYIKLWNGLVKVF RNERREGLIQARSIGAQKAKLGQVLIYLDAHCEVAVNWYAPLVAPISKDRTTCTVPLIDYIDGNDYSIEPQQGGDEDGFARGAWDWSLLW -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SAP30-GALNT7 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| Hgene | SAP30 | chr4:174295188 | chr4:174169131 | ENST00000296504 | + | 3 | 4 | 1_129 | 180.0 | 221.0 | NCOR1 |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | SAP30 | chr4:174295188 | chr4:174169131 | ENST00000296504 | + | 3 | 4 | 130_220 | 180.0 | 221.0 | SIN3A |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SAP30-GALNT7 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SAP30-GALNT7 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies